JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salganik, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salganik, R. I.

The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population

Rudolf I. Salganik, MD, PhD

University of North Carolina, Chapel Hill, North Carolina



View larger version (30K):

[in a new window]
 
Fig. 1. The main reactive oxygen species (ROS) that are constantly generated in living cells.

 


View larger version (19K):

[in a new window]
 
Fig. 2. The generation of ROS by mitochondria. Electrons released from mitochondria reduce oxygen molecules, thereby producing such ROS as superoxides (O2-). Superoxide dismutase (SOD) catalyzes H2O2 formation from superoxides. H2O2 might be deactivated by catalase (CAT). However, when H2O2 reacts with iron or copper ions, hydroxyl radicals (OH•), the most reactive form of ROS, are produced. Excessive antioxidants (AO) can inhibit production of O2- and other ROS.

 


View larger version (16K):

[in a new window]
 
Fig. 3. (a) ROS generated by microsomal monooxygenases, which have cytochrome P450 as a central link. Oxidation is the way to transform hydrophobic toxic substances, drugs, steroids etc., and thereby remove them. Excessive antioxidants can inhibit this protective function.

(b) ROS generated by phagocytes kill infectious microorganisms and cancer cells. Excessive antioxidants can inhibit this protective mechanism.

 


View larger version (20K):

[in a new window]
 
Fig. 4. Principal cellular antioxidants that scavenge or inactivate excessive ROS and thereby protect cells from oxidative damage.

 


View larger version (31K):

[in a new window]
 
Fig. 5. Schematic representation of apoptosis. ROS generated by mitochondria are essential mediators of apoptosis. Together with cytochrome C, Apaf-1, and ATP, released from mitochondria, ROS activate proteolytic enzymes, termed caspases, which promote deoxyribonuclease, and thereby destroy targeted "bad" cells.

 


View larger version (23K):

[in a new window]
 
Fig. 6. The anticancer drug, cisplatin, kills breast cancer cells by the induction of apoptosis. The antioxidant vitamin E inhibits the cisplatin-induced apoptotic death of cancer cells by scavenging ROS that are essential for carrying out apoptosis (see Fig. 7). MCF-7 breast cancer cells were grown in Eagle’s MEM in 6-well plates (4 x 104 cells per well) and incubated for 24 hours with 15 µM cisplatin. Vitamin E (15 µM) was added to the medium simultaneously with cisplatin or separately. Apoptosis was determined by TUNEL assay and morphological cell patterns [31].

 


View larger version (33K):

[in a new window]
 
Fig. 7. The antioxidant vitamin E inhibits cisplatin-induced ROS generation in cancer cells. The conditions of the experiment were as in Fig. 6. ROS generation was determined using the avidin-FITC which reacts specifically in apoptotic cells with 8-oxo-deoxyguanine, the biomarker of ROS generation, as described in reference [23].

 


View larger version (112K):

[in a new window]
 
Fig. 8. Increased oxidative stress results in enhanced apoptosis in the brain tumors of mice fed an antioxidant-devoid diet. The distribution of TUNEL-positive (black label, arrow) apoptotic cells in brain tumor for control (A) and in mice on the antioxidant-devoid diet (B) is shown. Oxidized guanine residues (8-oxo-Gua), biomarkers of ROS generation, were detected in brain tumors, using specific monoclonal antibodies (C and D) or an avidin-FITC conjugate (E and F). By both methods, cells in tumors of antioxidant-depleted mice (D and F) exhibit higher levels of 8-oxo-Gua residues than do cells in the tumors of control brains (C and E).

 


View larger version (105K):

[in a new window]
 
Fig. 9. The tumors of mice fed an antioxidant-depleted diet are reduced in size. Compared with tumors in mice fed a standard diet (A and B), the tumors in mice fed an antioxidant-depleted diet (C) were significantly smaller. Magnification: A= 60x; B and C= 120x.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Nutrition.